PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
25962668-1	2015	Genetically encoded p-azido-phenylalanine (azF) residues in G protein-coupled receptors (GPCRs) can be targeted with dibenzocyclooctyne-modified (DIBO-modified) fluorescent probes by means of strain-promoted [3+2] azide-alkyne cycloaddition (SpAAC).	4-azidophenylalanine	20-41	AZF1	Homo sapiens	43-46
33418637-3	2016	We recently reported the in vivo incorporation of UAAs, 4-substituted analogues of phenylalanine including 4-azidophenylalanine (AzPhe), into silk fibroin by expanding the repertoire of amino acids for protein biosynthesis in silk glands of B. mori using transgenic techniques.	4-azidophenylalanine	107-127	fibroin light chain	Bombyx mori	147-154
33418637-3	2016	We recently reported the in vivo incorporation of UAAs, 4-substituted analogues of phenylalanine including 4-azidophenylalanine (AzPhe), into silk fibroin by expanding the repertoire of amino acids for protein biosynthesis in silk glands of B. mori using transgenic techniques.	4-azidophenylalanine	129-134	fibroin light chain	Bombyx mori	147-154
33418637-4	2016	We demonstrated that azide groups in AzPhe incorporated into silk fibroin can be selectively modified by bioorthogonal azide-alkyne cycloaddition reactions (click chemistry).	4-azidophenylalanine	37-42	fibroin light chain	Bombyx mori	66-73
33418637-5	2016	However, the incorporation of AzPhe into silk fibroin required a special feeding condition, which led to the limited production of silk fibroin.	4-azidophenylalanine	30-35	fibroin light chain	Bombyx mori	46-53
33418637-5	2016	However, the incorporation of AzPhe into silk fibroin required a special feeding condition, which led to the limited production of silk fibroin.	4-azidophenylalanine	30-35	fibroin light chain	Bombyx mori	136-143
33418637-6	2016	Here we report more efficient production of an AzPhe-incorporated silk fibroin (termed AzidoSilk) and its modification by click chemistry in varied material forms (thread, film, and porous sponge).	4-azidophenylalanine	47-52	fibroin light chain	Bombyx mori	71-78
29560203-4	2015	Replacement of the buried L44 residue by photosensitive p-azidophenylalanine (azF) conferred environmentally sensitive photoswitching.	4-azidophenylalanine	56-76	AZF1	Homo sapiens	78-81
25676727-2	2015	Here we incorporated p-azido-phenylalanine (AzF) site-specifically into the proteins ubiquitin and GB1, and ligated the AzF residue with alkyne derivatives of small nitrilotriacetic acid and iminodiacetic acid tags using the Cu(I) -catalysed "click" reaction.	4-azidophenylalanine	21-42	AZF1	Homo sapiens	44-47
25676727-2	2015	Here we incorporated p-azido-phenylalanine (AzF) site-specifically into the proteins ubiquitin and GB1, and ligated the AzF residue with alkyne derivatives of small nitrilotriacetic acid and iminodiacetic acid tags using the Cu(I) -catalysed "click" reaction.	4-azidophenylalanine	21-42	gamma-aminobutyric acid type B receptor subunit 1	Homo sapiens	99-102
25676727-2	2015	Here we incorporated p-azido-phenylalanine (AzF) site-specifically into the proteins ubiquitin and GB1, and ligated the AzF residue with alkyne derivatives of small nitrilotriacetic acid and iminodiacetic acid tags using the Cu(I) -catalysed "click" reaction.	4-azidophenylalanine	21-42	AZF1	Homo sapiens	120-123
25157916-5	2014	The therapeutic agents described were generated using a click chemistry reaction between the unnatural amino acid (p-azidophenylalanine (pAzF)) incorporated into yCDtriple and the dibenzylcyclooctyne moiety of our PSMA targeting agent (DBCO-PEG4-AH2-TG97).	4-azidophenylalanine	115-135	folate hydrolase 1	Homo sapiens	214-218
15222748-5	2004	Photoactivatable derivatives of insulin containing respective p-azidophenylalanine substitutions at positions B24 and B25 were synthesized in an engineered monomer (DKP-insulin).	4-azidophenylalanine	62-82	insulin	Homo sapiens	32-39
20052681-6	2010	By this method, 4-azido-L-phenylalanine was incorporated into human interleukin-8 at a specific site.	4-azidophenylalanine	16-39	C-X-C motif chemokine ligand 8	Homo sapiens	68-81
16678132-1	2006	We constructed photo-reactive epidermal growth factor (EGF) bearing p-azido phenylalanine at the C-terminal (HEGFP) by genetic engineering to investigate the possibility of immobilized EGF as a novel artificial extracellular matrix (ECM).	4-azidophenylalanine	68-89	epidermal growth factor	Homo sapiens	30-53
16678132-1	2006	We constructed photo-reactive epidermal growth factor (EGF) bearing p-azido phenylalanine at the C-terminal (HEGFP) by genetic engineering to investigate the possibility of immobilized EGF as a novel artificial extracellular matrix (ECM).	4-azidophenylalanine	68-89	epidermal growth factor	Homo sapiens	55-58
32926023-2	2020	Herein, we engineer a chromodomain, an essential methyllysine reader, to carry 4-azido-l-phenylalanine (AzF) via amber suppressor mutagenesis and demonstrate its potential to bind and crosslink methylated proteins in human cells.	4-azidophenylalanine	79-102	AZF1	Homo sapiens	104-107
33672039-3	2021	We previously prolonged the plasma half-life of GLP-1 via site-specific conjugation of human serum albumin (HSA) at position 16 of recombinant GLP-1 using site-specific incorporation of p-azido-phenylalanine (AzF) and strain-promoted azide-alkyne cycloaddition (SPAAC).	4-azidophenylalanine	186-207	glucagon	Homo sapiens	48-53
33672039-3	2021	We previously prolonged the plasma half-life of GLP-1 via site-specific conjugation of human serum albumin (HSA) at position 16 of recombinant GLP-1 using site-specific incorporation of p-azido-phenylalanine (AzF) and strain-promoted azide-alkyne cycloaddition (SPAAC).	4-azidophenylalanine	186-207	albumin	Homo sapiens	93-106
33672039-3	2021	We previously prolonged the plasma half-life of GLP-1 via site-specific conjugation of human serum albumin (HSA) at position 16 of recombinant GLP-1 using site-specific incorporation of p-azido-phenylalanine (AzF) and strain-promoted azide-alkyne cycloaddition (SPAAC).	4-azidophenylalanine	186-207	AZF1	Homo sapiens	209-212
34990136-0	2022	Population Dynamics of Stretching Excitations of p-Azido-phenylalanine Incorporated in Calmodulin-Peptide Complexes.	4-azidophenylalanine	49-70	calmodulin 1	Homo sapiens	87-97
34990136-1	2022	We genetically incorporated the unnatural amino acid p-azido-phenylalanine (AzF) into the ubiquitous Ca2+ sensor protein calmodulin (CaM) in complex with different peptides to explore the response of the azido stretching line shape to varying binding motifs with femtosecond infrared spectroscopy.	4-azidophenylalanine	53-74	AZF1	Homo sapiens	76-79
34990136-1	2022	We genetically incorporated the unnatural amino acid p-azido-phenylalanine (AzF) into the ubiquitous Ca2+ sensor protein calmodulin (CaM) in complex with different peptides to explore the response of the azido stretching line shape to varying binding motifs with femtosecond infrared spectroscopy.	4-azidophenylalanine	53-74	calmodulin 1	Homo sapiens	121-131
34990136-1	2022	We genetically incorporated the unnatural amino acid p-azido-phenylalanine (AzF) into the ubiquitous Ca2+ sensor protein calmodulin (CaM) in complex with different peptides to explore the response of the azido stretching line shape to varying binding motifs with femtosecond infrared spectroscopy.	4-azidophenylalanine	53-74	calmodulin 1	Homo sapiens	133-136
30773887-4	2019	To engineer the point of attachment, we used amber codon reassignment to incorporate a synthetic amino acid, p-azidophenylalanine (azPhe), at specific locations within a single domain antibody (sdAb or nanobody) that recognizes the human epidermal growth factor receptor (EGFR).	4-azidophenylalanine	109-129	epidermal growth factor receptor	Homo sapiens	238-270
30773887-4	2019	To engineer the point of attachment, we used amber codon reassignment to incorporate a synthetic amino acid, p-azidophenylalanine (azPhe), at specific locations within a single domain antibody (sdAb or nanobody) that recognizes the human epidermal growth factor receptor (EGFR).	4-azidophenylalanine	109-129	epidermal growth factor receptor	Homo sapiens	272-276
30773887-4	2019	To engineer the point of attachment, we used amber codon reassignment to incorporate a synthetic amino acid, p-azidophenylalanine (azPhe), at specific locations within a single domain antibody (sdAb or nanobody) that recognizes the human epidermal growth factor receptor (EGFR).	4-azidophenylalanine	131-136	epidermal growth factor receptor	Homo sapiens	238-270
30773887-4	2019	To engineer the point of attachment, we used amber codon reassignment to incorporate a synthetic amino acid, p-azidophenylalanine (azPhe), at specific locations within a single domain antibody (sdAb or nanobody) that recognizes the human epidermal growth factor receptor (EGFR).	4-azidophenylalanine	131-136	epidermal growth factor receptor	Homo sapiens	272-276
30408949-5	2018	Using genetic code expansion technology, p-azidophenylalanine (AzF) was incorporated into a recombinant p19 protein and used to develop a fluorescence resonance energy transfer (FRET) sensor.	4-azidophenylalanine	41-61	AZF1	Homo sapiens	63-66
30408949-5	2018	Using genetic code expansion technology, p-azidophenylalanine (AzF) was incorporated into a recombinant p19 protein and used to develop a fluorescence resonance energy transfer (FRET) sensor.	4-azidophenylalanine	41-61	interleukin 23 subunit alpha	Homo sapiens	104-107
29429330-3	2018	The unnatural amino acid, 4-azidophenylalanine (4-AzF), was incorporated at different sites in the human ferritin light chain (hFTL) to allow site-specific conjugation of alkyne-containing small molecules or affinity ligands to the exterior surface of the nanocage.	4-azidophenylalanine	26-46	AZF1	Homo sapiens	50-53
29429330-3	2018	The unnatural amino acid, 4-azidophenylalanine (4-AzF), was incorporated at different sites in the human ferritin light chain (hFTL) to allow site-specific conjugation of alkyne-containing small molecules or affinity ligands to the exterior surface of the nanocage.	4-azidophenylalanine	26-46	ferritin light chain	Homo sapiens	105-125
29429330-3	2018	The unnatural amino acid, 4-azidophenylalanine (4-AzF), was incorporated at different sites in the human ferritin light chain (hFTL) to allow site-specific conjugation of alkyne-containing small molecules or affinity ligands to the exterior surface of the nanocage.	4-azidophenylalanine	26-46	ferritin light chain	Homo sapiens	127-131
28626565-5	2017	Using bromodomain-containing protein 4 (BRD4) as a paradigm, we engineer an "aromatic cage" of the bromodomain to introduce 4-azido-l-phenylalanine (pAzF) without compromising its ability to recognize acetylated lysine residues in histone proteins.	4-azidophenylalanine	124-147	bromodomain containing 4	Homo sapiens	6-38
28626565-5	2017	Using bromodomain-containing protein 4 (BRD4) as a paradigm, we engineer an "aromatic cage" of the bromodomain to introduce 4-azido-l-phenylalanine (pAzF) without compromising its ability to recognize acetylated lysine residues in histone proteins.	4-azidophenylalanine	124-147	bromodomain containing 4	Homo sapiens	40-44